Breast Surgery Bulletin

  Patients’ experiences with pre-test genetic counseling provided by breast cancer healthcare professionals: Results from a large prospectiv...

  Optimising post-operative radiation therapy after oncoplastic and reconstructive procedures by Trine Tramm, Orit Kaidar-Person  The Br...

  Tissue- and liquid biopsy-based biomarkers for immunotherapy in breast cancer by Luca Licata, Marco Mariani, Federico Rossari, Giulia Vi...

  Pathologic response and residual tumor cellularity after neo-adjuvant chemotherapy predict prognosis in breast cancer patients by Damian...

  Real-world comparative effectiveness of palbociclib plus letrozole versus letrozole in older patients with metastatic breast cancer by H...

  Future potential targets of antibody-drug conjugates in breast cancer   by Chiara Corti, Luca Boscolo Bielo, Ambra Carnevale Schianca,...

  Early increase in tamoxifen dose in CYP2D6 poor metaboliser breast cancer patients and survival: A propensity score matching analysis   ...

  Mammographic density and interval cancers in mammographic screening: Moving towards more personalized screening by Marthe Larsen, Elsebe...

  Radiotherapy including a boost should be delivered over no more than 3–4 weeks invited article for the Breast's upcoming SI “de-escala...

  Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review ...

  Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, ...

  Imaging of lumpectomy surface with large field-of-view confocal laser scanning microscopy ‘Histolog® scanner’ for breast margin assessment...

  Breast cancer, breast cancer-directed radiation therapy and risk of hypothyroidism: A systematic review and meta-analysis   by Elisabe...

  Diagnostic accuracy of a three-protein signature in women with suspicious breast lesions: a multicenter prospective trial Breast Cancer ...

  Cost-effectiveness of sacituzumab govitecan versus chemotherapy in advanced or metastatic triple-negative breast cancer by Yitian Lang, ...

  Early breast cancer in women aged 35 years or younger: A large national multicenter French population-based case control-matched analysis ...

  Taxane rechallenge during metastatic disease in HER-2 negative breast cancer patients: Clinical activity, tolerance and survival results ...

  Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a rand...

  Factors associated with weight gain after breast cancer: Results from a community-based survey of Australian women   by Carolyn Ee, Ad...